Total knee replacement can usually relieve pain and improve function, but a nonsurgical regimen can also be effective in some people without posing the complication risks that can plague people who choose surgery, according to a new study. Jeffrey N. Katz (Brigham and Women’s) authored an accompanying editorial to the study.
Positive news buoys a beleaguered field, but treatment benefits may fade. Eric Pierce (Mass. Eye & Ear) and Luk Vandenberghe (Mass. Eye & Ear) are quoted.
There is a new price surge in the pharmaceutical industry—for a limited number of government-issued vouchers that drug makers including, AbbVie Inc. and Sanofi SA, are buying to speed products to market. Aaron Kesselheim (Brigham and Women’s) is quoted.
The idea of using a patient’s biological information to improve and tailor treatment has gone from niche to mainstream. But as the practice gains popularity, experts point out a number of issues that the medical community has yet to tackle. Barrett Rollins (Dana-Farber) is quoted.
One of the most respected and influential groups in the continuing breast-cancer screening debate said on Tuesday that women should begin mammograms later and have them less frequently than it had long advocated. Nancy Keating (HMS) co-authored an editorial accompanying the new guidelines.
As hospitals have acquired more doctor practices, prices for outpatient medical services have gone up, according to a new study that will fuel debate over the impact of the merger boom sweeping through health care. J. Michael McWilliams (HMS) is author of the study.
